Brief: Celyad Oncology Announces Plan To Voluntarily Delist American Depository Shares From Nasdaq
05/05/2023 06:08
May 5 (Reuters) - Celyad Oncology SA CYAD.BR :
* ONCOLOGY ANNOUNCES INTENT TO VOLUNTARILY DELIST AMERICAN
DEPOSITORY SHARES FROM NASDAQ
* ANNOUNCED ITS BOD HAS APPROVED VOLUNTARY DELISTING OF ITS
AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES FROM
NASDAQ GLOBAL MARKET
* ANNOUNCED ITS BOD HAS APPROVED TERMINATION OF ITS AMERICAN
DEPOSITARY RECEIPT FACILITY AND DEREGISTRATION WITH U.S. SEC
* COMPANY WILL CONTINUE TO BE LISTED ON EURONEXT BRUSSELS
* COMPANY INTENDS TO FILE A FORM 25 WITH SEC ON OR ABOUT MAY
15,
2023
* DELISTING OF COMPANY'S ADSS WILL TAKE EFFECT NO EARLIER
THAN TEN
DAYS AFTER DATE OF THAT FORM 25 FILING
* COMPANY EXPECTS THAT AS A RESULT OF THIS VOLUNTARY
DELISTING,
LAST TRADING DAY OF ITS ORDINARY SHARES ON NASDAQ GLOBAL MARKET
WILL BE ON OR ABOUT MAY 24, 2023
Further company coverage: CYAD.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))